Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation.
2025 · 1st Quarter (Jan 1 - Mar 31)
THE BIOSIMILARS FORUM
Filed by THORN RUN PARTNERS.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 18, 2025
- Income
- $100,000.00
- Expenses
- Not reported
- Registrant
- THORN RUN PARTNERS
- Client
- THE BIOSIMILARS FORUM
- Filing UUID
- caa0e1a3-14da-4317-8a6d-4e821698c1df
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.